Control of iPTH levels with Vitamin D receptor activators- which include Calcitriol, Doxercalciferol, Paricalcitol, and Alfacalcidol-is associated with improved overall survival in chronic kidney disease (CKD) patients [8, 9]. This evidence concerns the gene VDR and chronic kidney disease.